Menlo Park, CA, United States of America

Theresa Anne Neumann

This inventor holds 1 USPTO granted patent. Top assignee: Prothena Biosciences Limited. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theresa Anne Neumann. Retrieved from https://idiyas.com/inventor/theresa-anne-neumann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Theresa Anne Neumann

Introduction

Theresa Anne Neumann is a prominent inventor based in Menlo Park, California. She has made significant strides in the field of immunotherapy, particularly in relation to Lewy body disease. Her innovative approach focuses on monitoring treatment effectiveness through the assessment of constipation symptoms.

Latest Patents

Neumann holds a patent for her invention titled "Monitoring immunotherapy of Lewy body disease from constipation symptoms." This invention provides methods for monitoring immunotherapy directed against alpha-synuclein by comparing a subject's constipation symptoms before treatment and at various times during and after treatment. The immunotherapeutic regime can be effectively monitored based on the results of the treatment.

Career Highlights

Theresa Anne Neumann has established herself as a key figure in the field of biomedical research. Her work at Prothena Biosciences Limited has allowed her to contribute to groundbreaking advancements in the treatment of neurodegenerative diseases. With her expertise, she has been able to bridge the gap between clinical practice and innovative research.

Collaborations

Neumann has collaborated with notable colleagues such as Gene Kinney and Daniel Keith Ness. These partnerships have further enhanced her research capabilities and have contributed to the success of her projects.

Conclusion

Theresa Anne Neumann's contributions to the field of immunotherapy exemplify the impact of innovative thinking in medical research. Her patent and collaborative efforts highlight her commitment to improving treatment outcomes for patients with Lewy body disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…